NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | Healthcare | Biotechnology | 2.29% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 2.22% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 1.95% |
| YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.79% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 1.79% |
| TSVT | 2Seventy Bio Inc | Healthcare | Biotechnology | 1.78% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 1.78% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 1.73% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 1.71% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.70% |
| IPHA | Innate Pharma | Healthcare | Biotechnology | 1.68% |
| IDYA | Ideaya Biosciences Inc | Healthcare | Biotechnology | 1.68% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 1.68% |
| DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 1.67% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.65% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.65% |
| JANX | Janux Therapeutics Inc | Healthcare | Biotechnology | 1.65% |